Follow The Filings

IRON Disc Medicine

Disc Medicine earnings company data as of 4:45 AM ET 11/1

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS -1.71 — —
Rev — — —

Insider trades

Open-market buys and sales by IRON's executives, directors and 10% owners in the last 12 months, from their Form 4s

All IRON insider trades
  • None no insider bought on the open market
  • $18.8M sold by 1 insider outside a trading plan
  • $29.1M sold by 6 insiders under 10b5-1 plans
  1. Kevin Bitterman Director
    Planned sale
    $3.4M 41,825 shares at $80.13 76% of stake
    Traded Oct 19–21 Filed Oct 21
    ↗
  2. Kevin Bitterman Director
    Sale
    $1.9M 27,136 shares at $70.11 100% of stake
    Traded Sep 11 Filed Sep 15
    ↗
  3. Kevin Bitterman Director
    Planned sale
    $135K 1,689 shares at $79.96 11% of stake
    Traded Sep 4 Filed Sep 9
    ↗
  4. Kevin Bitterman Director
    Planned sale
    $4.4M 54,496 shares at $80.15 80% of stake
    Traded Sep 1–3 Filed Sep 3
    ↗
  5. Jonathan Yen-Wen Yu COO
    Planned sale
    $756K 9,096 shares at $83.10 14% of stake
    Traded Aug 24–25 Filed Aug 26
    ↗
  6. John D Quisel CEO
    Planned sale
    $2.6M 33,000 shares at $79.15 13% of stake
    Traded Aug 17 Filed Aug 18
    ↗
  7. Jonathan Yen-Wen Yu COO
    Planned sale
    $66K 804 shares at $82.64 1.5% of stake
    Traded Aug 12 Filed Aug 14
    ↗
  8. Rahul Khara Chief Legal Officer
    Planned sale
    $400K 5,000 shares at $80.00 8.7% of stake
    Traded Aug 6 Filed Aug 7
    ↗
  9. John D Quisel CEO
    Planned sale
    $2.5M 33,000 shares at $74.96 13% of stake
    Traded Jul 13 Filed Jul 14
    ↗
  10. Jonathan Yen-Wen Yu COO
    Planned sale
    $8,250 100 shares at $82.50 0.2% of stake
    Traded Jul 7 Filed Jul 9
    ↗
  11. Rahul Khara Chief Legal Officer
    Planned sale
    $188K 2,500 shares at $75.00 4.6% of stake
    Traded Jun 26–29 Filed Jun 30
    ↗
  12. Jonathan Yen-Wen Yu COO
    Planned sale
    $22K 300 shares at $72.50 0.5% of stake
    Traded Jun 26 Filed Jun 30
    ↗
  13. Jonathan Yen-Wen Yu COO
    Planned sale
    $705K 9,700 shares at $72.66 15% of stake
    Traded Jun 22 Filed Jun 24
    ↗
  14. Rahul Khara Chief Legal Officer
    Planned sale
    $527K 7,500 shares at $70.22 13% of stake
    Traded Jun 18 Filed Jun 23
    ↗
  15. John D Quisel CEO
    Planned sale
    $2.4M 34,000 shares at $70.21 13% of stake
    Traded Jun 18 Filed Jun 23
    ↗

Also filed in the last 12 months, not counted as buying or selling: 29 option exercises, 6 stock grants, and 6 sales to cover taxes.

SEC filings

Recent issuer filings from EDGAR, 15 shown.

Filed Form Detail Links
SCHEDULE 13D/A — Filing Doc
8-K 1.01,2.02,8.01,9.01 Filing Doc
424B5 Filing Doc
424B5 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 1.01,2.03 Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.